Compare Viva Biotech Holdings with Similar Stocks
Dashboard
1
High Debt company with Weak Long Term Fundamental Strength
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 1.66% signifying low profitability per unit of shareholders funds
2
Flat results in Dec 25
3
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-38.77%
0%
-38.77%
6 Months
-24.86%
0%
-24.86%
1 Year
-16.27%
0%
-16.27%
2 Years
90.41%
0%
90.41%
3 Years
2.96%
0%
2.96%
4 Years
-41.1%
0%
-41.1%
5 Years
-83.23%
0%
-83.23%
Viva Biotech Holdings for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
36.46%
EBIT Growth (5y)
29.19%
EBIT to Interest (avg)
1.98
Debt to EBITDA (avg)
2.22
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
0.35
Tax Ratio
24.92%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
4.47%
ROE (avg)
1.66%
Valuation key factors
Factor
Value
P/E Ratio
28
Industry P/E
Price to Book Value
1.20
EV to EBIT
21.67
EV to EBITDA
11.05
EV to Capital Employed
1.19
EV to Sales
2.70
PEG Ratio
0.18
Dividend Yield
NA
ROCE (Latest)
5.51%
ROE (Latest)
4.23%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.01%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,875.60
2,154.00
-12.92%
Operating Profit (PBDIT) excl Other Income
438.50
480.90
-8.82%
Interest
40.70
58.40
-30.31%
Exceptional Items
146.10
48.90
198.77%
Consolidate Net Profit
292.00
240.70
21.31%
Operating Profit Margin (Excl OI)
111.70%
115.60%
-0.39%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -12.92% vs -9.57% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 21.31% vs 318.22% in Dec 2024
About Viva Biotech Holdings 
Viva Biotech Holdings
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






